[Hypoglycemia. 3].
D001645:Biguanides / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003927:Diet, Diabetic; D000431:Ethanol / Q000009:adverse effects; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007328:Insulin / Q000009:adverse effects; D007930:Leucine / Q000009:adverse effects; D010939:Plant Poisoning / Q000150:complications; D013449:Sulfonamides / Q000009:adverse effects; D013566:Sympathomimetics / Q000627:therapeutic use; D014044:Tolbutamide / Q000009:adverse effects
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D013449:Sulfonamides; D013566:Sympathomimetics; D000431:Ethanol; D003520:Cyclophosphamide; D005934:Glucagon; D014044:Tolbutamide; D007930:Leucine
Hypoglykämie. 3.